Signal from the log
Sensydia
plus de 6 M$ · Undisclosed · United States · Medtech
Sensydia mesure la pression dans les artères du poumon sans cathéter, en analysant par intelligence artificielle les sons et les signaux électriques du cœur. Son appareil vise le suivi de l'insuffisance cardiaque et de l'hypertension pulmonaire au cabinet ; la levée, menée par Colle Capital Partners, doit le conduire jusqu'à l'autorisation de la FDA.
Article
Announced on , logged by the watch of 13 October 2026.
- Operation
- Funding round
- Announced amount
- plus de 6 M$
- Stage
- Undisclosed
- Country
- United States
- Sector
- Medtech
What the log says
Editorial note, in French
Sujet traité. L'article donne les sources et la position de Bolus.
The investors
Led by Colle Capital Partners , with Orlando Health Ventures
Provenance
Source prnewswire
Logged on 13 October 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Article The operation led to an article, with its sources checked one by one.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.